Cargando…

A combined phase I/IIa study of the safety, bronchodilator and bronchoprotective effects of nebulized RPL554, a dual PDE3/4-inhibitor, in healthy subjects and asthmatics

Detalles Bibliográficos
Autores principales:	Franciosi, Luigi, Diamant, Zuzana, Morelli, Nicoletta, de Kam, Marieke, Cohen, Adam, Walker, Michael, Page, Clive
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647361/ http://dx.doi.org/10.1186/2045-7022-3-S1-O13

Ejemplares similares

The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD
por: Singh, Dave, et al.
Publicado: (2018)

Bronchodilator response after two methods of salbutamol nebulization in asthmatic children
por: Emeryk, Andrzej, et al.
Publicado: (2022)

Sulforaphane improves the bronchoprotective response in asthmatics through Nrf2-mediated gene pathways
por: Brown, Robert H., et al.
Publicado: (2015)

Patterns of bronchodilator therapy in asthmatic outpatients
por: Aryani, Toetik, et al.
Publicado: (2023)

Prescribing patterns of nebulized bronchodilators: A prospective chart review
por: Yaxley, Julian P.
Publicado: (2016)

Nasal high-flow bronchodilator nebulization: a randomized cross-over study
por: Reminiac, François, et al.
Publicado: (2018)

Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD
por: Donohue, James F, et al.
Publicado: (2019)

A genome-wide association study of bronchodilator response in asthmatics
por: Duan, Qing Ling, et al.
Publicado: (2013)

Age by Single Nucleotide Polymorphism Interactions on Bronchodilator Response in Asthmatics
por: Voorhies, Kirsten, et al.
Publicado: (2021)

Loss of bronchoprotection to Salbutamol during sputum induction with hypertonic saline: implications for asthma therapy
por: Wang, Hongyu, et al.
Publicado: (2018)

Allosteric modulator potentiates β(2)AR agonist–promoted bronchoprotection in asthma models
por: Ahn, Seungkirl, et al.
Publicado: (2023)

Daily Use of Salmeterol Causes Tolerance to Bronchodilation with Terbutaline in Asthmatic Subjects
por: Elers, Jimmi, et al.
Publicado: (2010)

A bronchoprotective role for Rgs2 in a murine model of lipopolysaccharide-induced airways inflammation
por: George, Tresa, et al.
Publicado: (2018)

Replacing nebulizers by MDI-spacers for bronchodilator and inhaled corticosteroid administration: Impact on the utilization of hospital resources
por: Alhaider, S.A., et al.
Publicado: (2014)

A polymorphism in the thyroid hormone receptor gene is associated with bronchodilator response in asthmatics
por: Duan, Qing Ling, et al.
Publicado: (2012)

Comparison of the Clinical Efficacy of Salbutamol with Jet and Mesh Nebulizers in Asthmatic Children
por: Murayama, Norihide, et al.
Publicado: (2018)

Improved bioavailability of cromolyn sodium using inhaled PA101 delivered via eFlow® nebulizer
por: Abd-Elaziz, Khalid, et al.
Publicado: (2020)

Influence of Mechanical Ventilation Modes on the Efficacy of Nebulized Bronchodilators in the Treatment of Intubated Adult Patients with Obstructive Pulmonary Disease
por: Lima, Cibelle Andrade, et al.
Publicado: (2023)

Kinetics of TH2 biomarkers in sputum of asthmatics following inhaled allergen
por: Zuiker, Rob G. J. A., et al.
Publicado: (2015)

CCNA Security 640-554 quick reference
por: Sequeira, Anthony
Publicado: (2012)

Does Good Nebulization Therapy in the Emergency Room Reduce the Need for Hospitalization in Asthmatic Children?
por: Almazroea, Abdulhadi H, et al.
Publicado: (2023)

CCNA Security 640-554 Official Cert Guide
por: Barker, Keith
Publicado: (2012)

CCNA Security (640-554) Portable Command Guide
por: Vachon, Bob
Publicado: (2012)

CCNA Security 640-554 official cert guide
por: Barker, Keith, et al.
Publicado: (2013)

Correction to Lancet Oncol 2012; 13: 549, 554
Publicado: (2013)

The Bronchoprotective Effects of Dual Pharmacology, Muscarinic Receptor Antagonist and β(2) Adrenergic Receptor Agonist Navafenterol in Human Small Airways
por: Jude, Joseph Antony, et al.
Publicado: (2023)

Cysteinyl–leukotriene and prostaglandin pathways in bronchial versus alveolar lavage in allergic asthmatics
por: van der Burg, Nicole, et al.
Publicado: (2022)

The future of bronchodilation: looking for new classes of bronchodilators
por: Cazzola, Mario, et al.
Publicado: (2019)

Looking for God in a busted particle (PRESSCUT-S-2005-554)
por: Calamai, Peter
Publicado: (2005)

SAT-554 Teprotumumab in Graves' Orbitopathy: Extended Outcome Analyses
por: Kahaly, George, et al.
Publicado: (2019)

Nebulized levofloxacin for chronic Burkholderia cenocepacia pulmonary infection in cystic fibrosis: A case report
por: Dagenais, Renée VE., et al.
Publicado: (2022)

Evidence of Horizontal Gene Transfer of 50S Ribosomal Genes rplB, rplD, and rplY in Neisseria gonorrhoeae
por: Manoharan-Basil, Sheeba Santhini, et al.
Publicado: (2021)

Vital capacity and inspiratory capacity as additional parameters to evaluate bronchodilator response in asthmatic patients: a cross sectional study
por: Azevedo, Karen S, et al.
Publicado: (2012)

Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary disease
por: Leaker, Brian R., et al.
Publicado: (2019)

Modified Small-Volume Jet Nebulizer Based on CFD Simulation and Its Clinical Outcomes in Small Asthmatic Children
por: Santati, Sermsri, et al.
Publicado: (2019)

SAT-554 Genetic Profile of Early-Onset Aldosterone-Producing Adenomas
por: Baker, Jessica E, et al.
Publicado: (2020)

FRI554 Pretibial Myxedema Associated With Hashimoto Thyroiditis Treated With Teprotumumab
por: Marta Niedzialkowska, Ewelina, et al.
Publicado: (2023)

SAT554 Follicular Variant of PTCA Initially Presenting with Widespread Metastases
por: Natividad Bisquera, Nichole Andrea, et al.
Publicado: (2023)

Preventive nebulization of mucolytic agents and bronchodilating drugs in invasively ventilated intensive care unit patients (NEBULAE): study protocol for a randomized controlled trial
por: van der Hoeven, Sophia M., et al.
Publicado: (2015)

554. Does Protease Inhibitor (PI) Monotherapy Select Primary PI Resistance?
por: Saling, Christopher, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qgft7krm5algn0tt6m80t86sd2